Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses.
Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.
Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Clinical and epidemiological profiles of non-traumatic myelopathies.
Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Unilateral internuclear ophthalmoplegia after minor head injury.
Acute demyelinating disorders of the central nervous system.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study.
Comparison of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Treated With Disease Modifying Treatments (Dmt) In Europe (Eu) And The United States (Us).
Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms).
A steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Pages
« first
‹ previous
…
716
717
718
719
720
721
722
723
724
…
next ›
last »